CA2766157A1 - Methods for diagnosing irritable bowel syndrome - Google Patents

Info

Publication number

CA2766157A1

CA2766157A1 CA2766157A CA2766157A CA2766157A1 CA 2766157 A1 CA2766157 A1 CA 2766157A1 CA 2766157 A CA2766157 A CA 2766157A CA 2766157 A CA2766157 A CA 2766157A CA 2766157 A1 CA2766157 A1 CA 2766157A1

Authority

CA

Canada

Prior art keywords

sample

ibs

level

subject

tryptase

Prior art date

2009-06-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 208000002551 irritable bowel syndrome Diseases 0.000 title claims abstract description 486
• 238000000034 method Methods 0.000 title claims abstract description 332
• NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims abstract description 314
• 210000002966 serum Anatomy 0.000 claims abstract description 226
• 238000003556 assay Methods 0.000 claims abstract description 181
• 229960001340 histamine Drugs 0.000 claims abstract description 156
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims abstract description 151
• 229960002986 dinoprostone Drugs 0.000 claims abstract description 76
• XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 claims abstract description 75
• 238000003745 diagnosis Methods 0.000 claims abstract description 59
• 239000000758 substrate Substances 0.000 claims abstract description 33
• 102000002260 Alkaline Phosphatase Human genes 0.000 claims abstract description 14
• 108020004774 Alkaline Phosphatase Proteins 0.000 claims abstract description 14
• 102100032219 Cathepsin D Human genes 0.000 claims abstract description 13
• 101000869010 Homo sapiens Cathepsin D Proteins 0.000 claims abstract description 13
• 230000035945 sensitivity Effects 0.000 claims abstract description 11
• 239000000523 sample Substances 0.000 claims description 695
• 210000004369 blood Anatomy 0.000 claims description 197
• 239000008280 blood Substances 0.000 claims description 197
• 208000024891 symptom Diseases 0.000 claims description 184
• 239000003550 marker Substances 0.000 claims description 151
• 239000000090 biomarker Substances 0.000 claims description 93
• 108010051335 Lipocalin-2 Proteins 0.000 claims description 74
• 102000013519 Lipocalin-2 Human genes 0.000 claims description 74
• 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 claims description 73
• 108010037645 Cytokine TWEAK Proteins 0.000 claims description 71
• 230000027455 binding Effects 0.000 claims description 59
• 102000005353 Tissue Inhibitor of Metalloproteinase-1 Human genes 0.000 claims description 56
• 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 claims description 56
• 230000001965 increasing effect Effects 0.000 claims description 54
• LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 claims description 50
• 102000003777 Interleukin-1 beta Human genes 0.000 claims description 50
• 108090000193 Interleukin-1 beta Proteins 0.000 claims description 50
• 238000002965 ELISA Methods 0.000 claims description 47
• 108700039882 Protein Glutamine gamma Glutamyltransferase 2 Proteins 0.000 claims description 47
• 102100038095 Protein-glutamine gamma-glutamyltransferase 2 Human genes 0.000 claims description 47
• 102000016950 Chemokine CXCL1 Human genes 0.000 claims description 44
• 108010014419 Chemokine CXCL1 Proteins 0.000 claims description 44
• 238000001514 detection method Methods 0.000 claims description 43
• 230000013016 learning Effects 0.000 claims description 43
• 230000008569 process Effects 0.000 claims description 40
• 239000012472 biological sample Substances 0.000 claims description 38
• 210000000440 neutrophil Anatomy 0.000 claims description 38
• 238000004422 calculation algorithm Methods 0.000 claims description 37
• 238000012896 Statistical algorithm Methods 0.000 claims description 32
• 239000003814 drug Substances 0.000 claims description 31
• 230000001086 cytosolic effect Effects 0.000 claims description 30
• 229940079593 drug Drugs 0.000 claims description 29
• 206010012735 Diarrhoea Diseases 0.000 claims description 27
• 239000003076 neurotropic agent Substances 0.000 claims description 24
• 206010010774 Constipation Diseases 0.000 claims description 22
• 238000012544 monitoring process Methods 0.000 claims description 19
• 206010000060 Abdominal distension Diseases 0.000 claims description 18
• 208000004998 Abdominal Pain Diseases 0.000 claims description 16
• 238000007637 random forest analysis Methods 0.000 claims description 16
• 238000013528 artificial neural network Methods 0.000 claims description 14
• 238000012545 processing Methods 0.000 claims description 14
• 235000012054 meals Nutrition 0.000 claims description 12
• 230000002829 reductive effect Effects 0.000 claims description 12
• 102000000589 Interleukin-1 Human genes 0.000 claims description 10
• 108010002352 Interleukin-1 Proteins 0.000 claims description 10
• 206010000059 abdominal discomfort Diseases 0.000 claims description 10
• 208000024330 bloating Diseases 0.000 claims description 10
• 208000015181 infectious disease Diseases 0.000 claims description 9
• 238000003118 sandwich ELISA Methods 0.000 claims description 9
• 239000007790 solid phase Substances 0.000 claims description 8
• 208000002193 Pain Diseases 0.000 claims description 7
• 201000006549 dyspepsia Diseases 0.000 claims description 7
• 230000036407 pain Effects 0.000 claims description 7
• 206010008479 Chest Pain Diseases 0.000 claims description 6
• 206010008469 Chest discomfort Diseases 0.000 claims description 6
• 206010058672 Negative thoughts Diseases 0.000 claims description 6
• 208000024798 heartburn Diseases 0.000 claims description 6
• 239000011248 coating agent Substances 0.000 claims description 3
• 238000000576 coating method Methods 0.000 claims description 3
• 108060005989 Tryptase Proteins 0.000 abstract description 33
• 102000001400 Tryptase Human genes 0.000 abstract description 32
• 210000003630 histaminocyte Anatomy 0.000 abstract description 9
• 241000283973 Oryctolagus cuniculus Species 0.000 abstract description 2
• 238000012286 ELISA Assay Methods 0.000 abstract 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 70
• 102000004169 proteins and genes Human genes 0.000 description 65
• 108090000623 proteins and genes Proteins 0.000 description 64
• 235000018102 proteins Nutrition 0.000 description 52
• 238000001574 biopsy Methods 0.000 description 44
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 37
• -1 tryptase) Chemical compound 0.000 description 34
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 33
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 33
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 33
• 108090000765 processed proteins & peptides Proteins 0.000 description 30
• 230000014509 gene expression Effects 0.000 description 29
• 102000004127 Cytokines Human genes 0.000 description 28
• 108090000695 Cytokines Proteins 0.000 description 28
• 239000000427 antigen Substances 0.000 description 28
• 108091007433 antigens Proteins 0.000 description 28
• 102000036639 antigens Human genes 0.000 description 28
• 102000004190 Enzymes Human genes 0.000 description 27
• 108090000790 Enzymes Proteins 0.000 description 27
• 229940088598 enzyme Drugs 0.000 description 27
• 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 26
• 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 26
• 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 26
• 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 description 26
• 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 description 26
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 26
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 26
• 230000002055 immunohistochemical effect Effects 0.000 description 26
• 210000002381 plasma Anatomy 0.000 description 25
• 102000019298 Lipocalin Human genes 0.000 description 24
• 108050006654 Lipocalin Proteins 0.000 description 24
• 150000001413 amino acids Chemical group 0.000 description 24
• 238000003018 immunoassay Methods 0.000 description 24
• 102000004196 processed proteins & peptides Human genes 0.000 description 24
• 108010074051 C-Reactive Protein Proteins 0.000 description 22
• 102100032752 C-reactive protein Human genes 0.000 description 22
• 208000015943 Coeliac disease Diseases 0.000 description 22
• 201000010099 disease Diseases 0.000 description 22
• 102000008108 Osteoprotegerin Human genes 0.000 description 21
• 108010035042 Osteoprotegerin Proteins 0.000 description 21
• 102000005876 Tissue Inhibitor of Metalloproteinases Human genes 0.000 description 21
• 108010005246 Tissue Inhibitor of Metalloproteinases Proteins 0.000 description 21
• 230000003321 amplification Effects 0.000 description 21
• BGHSOEHUOOAYMY-JTZMCQEISA-N ghrelin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CN)C1=CC=CC=C1 BGHSOEHUOOAYMY-JTZMCQEISA-N 0.000 description 21
• 238000009396 hybridization Methods 0.000 description 21
• 238000003199 nucleic acid amplification method Methods 0.000 description 21
• 229920001184 polypeptide Polymers 0.000 description 21
• 102000013674 S-100 Human genes 0.000 description 20
• 108700021018 S100 Proteins 0.000 description 20
• KLVRDXBAMSPYKH-RKYZNNDCSA-N corticotropin-releasing hormone (human) Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(N)=O)[C@@H](C)CC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(C)C)C1=CNC=N1 KLVRDXBAMSPYKH-RKYZNNDCSA-N 0.000 description 20
• 210000002700 urine Anatomy 0.000 description 20
• 108010063045 Lactoferrin Proteins 0.000 description 19
• 102000010445 Lactoferrin Human genes 0.000 description 19
• 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 19
• 229940041967 corticotropin-releasing hormone Drugs 0.000 description 19
• 239000003102 growth factor Substances 0.000 description 19
• CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 19
• 229940078795 lactoferrin Drugs 0.000 description 19
• 235000021242 lactoferrin Nutrition 0.000 description 19
• XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 19
• 101800001586 Ghrelin Proteins 0.000 description 18
• 102400000442 Ghrelin-28 Human genes 0.000 description 18
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 18
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 18
• 102100036154 Platelet basic protein Human genes 0.000 description 18
• 102100030304 Platelet factor 4 Human genes 0.000 description 18
• 239000012634 fragment Substances 0.000 description 18
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 18
• 150000003180 prostaglandins Chemical class 0.000 description 18
• 241001408449 Asca Species 0.000 description 17
• 108010092277 Leptin Proteins 0.000 description 17
• 102000016267 Leptin Human genes 0.000 description 17
• 229940039781 leptin Drugs 0.000 description 17
• 108010033760 Amphiregulin Proteins 0.000 description 16
• 238000008157 ELISA kit Methods 0.000 description 16
• 102000003141 Tachykinin Human genes 0.000 description 16
• 210000001035 gastrointestinal tract Anatomy 0.000 description 16
• 108060008037 tachykinin Proteins 0.000 description 16
• 102100035846 Pigment epithelium-derived factor Human genes 0.000 description 15
• 230000004069 differentiation Effects 0.000 description 15
• 208000035475 disorder Diseases 0.000 description 15
• PCJGZPGTCUMMOT-ISULXFBGSA-N neurotensin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 PCJGZPGTCUMMOT-ISULXFBGSA-N 0.000 description 15
• 102400001103 Neurotensin Human genes 0.000 description 14
• 101800001814 Neurotensin Proteins 0.000 description 14
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 13
• 102000012479 Serine Proteases Human genes 0.000 description 13
• 108010022999 Serine Proteases Proteins 0.000 description 13
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 13
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 13
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 13
• 210000004027 cell Anatomy 0.000 description 13
• 230000000670 limiting effect Effects 0.000 description 13
• 108020004999 messenger RNA Proteins 0.000 description 13
• 108090000102 pigment epithelium-derived factor Proteins 0.000 description 13
• 210000003296 saliva Anatomy 0.000 description 13
• 102000002572 Alpha-Globulins Human genes 0.000 description 12
• 108010068307 Alpha-Globulins Proteins 0.000 description 12
• 102000007299 Amphiregulin Human genes 0.000 description 12
• 102100025255 Haptoglobin Human genes 0.000 description 12
• 241000282414 Homo sapiens Species 0.000 description 12
• 102000004890 Interleukin-8 Human genes 0.000 description 12
• 108090001007 Interleukin-8 Proteins 0.000 description 12
• 102100033467 L-selectin Human genes 0.000 description 12
• 102100034686 Tight junction protein ZO-1 Human genes 0.000 description 12
• 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 12
• 102400000015 Vasoactive intestinal peptide Human genes 0.000 description 12
• 108700007340 Zonula Occludens-1 Proteins 0.000 description 12
• 235000001014 amino acid Nutrition 0.000 description 12
• 230000000845 anti-microbial effect Effects 0.000 description 12
• VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 12
• 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 11
• 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 11
• 108090001064 Gelsolin Proteins 0.000 description 11
• 108050005077 Haptoglobin Proteins 0.000 description 11
• 206010028980 Neoplasm Diseases 0.000 description 11
• 108010061952 Orosomucoid Proteins 0.000 description 11
• 102000012404 Orosomucoid Human genes 0.000 description 11
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 11
• 230000002550 fecal effect Effects 0.000 description 11
• 230000004054 inflammatory process Effects 0.000 description 11
• 230000000968 intestinal effect Effects 0.000 description 11
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 10
• 208000018522 Gastrointestinal disease Diseases 0.000 description 10
• 201000011510 cancer Diseases 0.000 description 10
• 238000010166 immunofluorescence Methods 0.000 description 10
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 10
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 10
• QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 9
• JWICNZAGYSIBAR-LEEGLKINSA-N (4s)-4-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-aminopropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-5-[[2-[[(2s)-3-carboxy-1-[[(2s)-1-[[1-[[(2s)-1-[[(2s)-4-carboxy-1-[[2-[[2-[[2-[[(2s)-1-[[(1s)-1-carboxy-4-(diaminomethylideneamino Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)C(CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)N)CC1=CC=CC=C1 JWICNZAGYSIBAR-LEEGLKINSA-N 0.000 description 9
• 206010009900 Colitis ulcerative Diseases 0.000 description 9
• 101800000974 Fibrinopeptide A Proteins 0.000 description 9
• 102400000525 Fibrinopeptide A Human genes 0.000 description 9
• 102000004878 Gelsolin Human genes 0.000 description 9
• 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 9
• 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 description 9
• 206010061218 Inflammation Diseases 0.000 description 9
• 108700028353 OmpC Proteins 0.000 description 9
• 102000016387 Pancreatic elastase Human genes 0.000 description 9
• 108010067372 Pancreatic elastase Proteins 0.000 description 9
• 108090000778 Platelet factor 4 Proteins 0.000 description 9
• 102400000096 Substance P Human genes 0.000 description 9
• 101800003906 Substance P Proteins 0.000 description 9
• 201000006704 Ulcerative Colitis Diseases 0.000 description 9
• 210000001072 colon Anatomy 0.000 description 9
• 208000010643 digestive system disease Diseases 0.000 description 9
• 208000018685 gastrointestinal system disease Diseases 0.000 description 9
• 108010040721 Flagellin Proteins 0.000 description 8
• 102000006395 Globulins Human genes 0.000 description 8
• 108010044091 Globulins Proteins 0.000 description 8
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 8
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 8
• 230000000356 anti-lactoferrin effect Effects 0.000 description 8
• 230000001580 bacterial effect Effects 0.000 description 8
• 239000002609 medium Substances 0.000 description 8
• 210000001519 tissue Anatomy 0.000 description 8
• 102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 7
• 208000011231 Crohn disease Diseases 0.000 description 7
• 102400001368 Epidermal growth factor Human genes 0.000 description 7
• 101800003838 Epidermal growth factor Proteins 0.000 description 7
• 230000008859 change Effects 0.000 description 7
• 229940116977 epidermal growth factor Drugs 0.000 description 7
• 239000002350 fibrinopeptide Substances 0.000 description 7
• 208000008275 microscopic colitis Diseases 0.000 description 7
• 108010075437 phosphopeptidomannan Proteins 0.000 description 7
• 108010052500 Calgranulin A Proteins 0.000 description 6
• 206010012742 Diarrhoea infectious Diseases 0.000 description 6
• 102400000921 Gastrin Human genes 0.000 description 6
• 108010052343 Gastrins Proteins 0.000 description 6
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 6
• 108010092694 L-Selectin Proteins 0.000 description 6
• 102100032442 Protein S100-A8 Human genes 0.000 description 6
• 238000010240 RT-PCR analysis Methods 0.000 description 6
• 108700028909 Serum Amyloid A Proteins 0.000 description 6
• 102000054727 Serum Amyloid A Human genes 0.000 description 6
• AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 6
• 230000000052 comparative effect Effects 0.000 description 6
• 230000001276 controlling effect Effects 0.000 description 6
• 238000011161 development Methods 0.000 description 6
• 230000018109 developmental process Effects 0.000 description 6
• 208000037765 diseases and disorders Diseases 0.000 description 6
• 208000001848 dysentery Diseases 0.000 description 6
• 230000006870 function Effects 0.000 description 6
• 208000021302 gastroesophageal reflux disease Diseases 0.000 description 6
• 238000011160 research Methods 0.000 description 6
• 230000004044 response Effects 0.000 description 6
• 210000000813 small intestine Anatomy 0.000 description 6
• 102100038778 Amphiregulin Human genes 0.000 description 5
• QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 5
• 230000003872 anastomosis Effects 0.000 description 5
• 230000001684 chronic effect Effects 0.000 description 5
• DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 5
• 208000007784 diverticulitis Diseases 0.000 description 5
• 210000003608 fece Anatomy 0.000 description 5
• 239000003446 ligand Substances 0.000 description 5
• 230000004048 modification Effects 0.000 description 5
• 238000012986 modification Methods 0.000 description 5
• 210000004877 mucosa Anatomy 0.000 description 5
• 229940094443 oxytocics prostaglandins Drugs 0.000 description 5
• CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 238000011282 treatment Methods 0.000 description 5
• 102100036850 C-C motif chemokine 23 Human genes 0.000 description 4
• 108010052495 Calgranulin B Proteins 0.000 description 4
• 102000001554 Hemoglobins Human genes 0.000 description 4
• 108010054147 Hemoglobins Proteins 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101000795074 Homo sapiens Tryptase alpha/beta-1 Proteins 0.000 description 4
• 102100032420 Protein S100-A9 Human genes 0.000 description 4
• 208000005718 Stomach Neoplasms Diseases 0.000 description 4
• 102100029639 Tryptase alpha/beta-1 Human genes 0.000 description 4
• 208000038016 acute inflammation Diseases 0.000 description 4
• 230000006022 acute inflammation Effects 0.000 description 4
• 238000004458 analytical method Methods 0.000 description 4
• 239000005557 antagonist Substances 0.000 description 4
• 210000001124 body fluid Anatomy 0.000 description 4
• 239000000812 cholinergic antagonist Substances 0.000 description 4
• 208000008609 collagenous colitis Diseases 0.000 description 4
• 238000013461 design Methods 0.000 description 4
• 230000000694 effects Effects 0.000 description 4
• 208000027866 inflammatory disease Diseases 0.000 description 4
• 210000000265 leukocyte Anatomy 0.000 description 4
• 230000000813 microbial effect Effects 0.000 description 4
• 239000002243 precursor Substances 0.000 description 4
• 239000006041 probiotic Substances 0.000 description 4
• 235000018291 probiotics Nutrition 0.000 description 4
• 238000004393 prognosis Methods 0.000 description 4
• BBNQQADTFFCFGB-UHFFFAOYSA-N purpurin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC(O)=C3C(=O)C2=C1 BBNQQADTFFCFGB-UHFFFAOYSA-N 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 210000002784 stomach Anatomy 0.000 description 4
• 230000001755 vocal effect Effects 0.000 description 4
• 230000004580 weight loss Effects 0.000 description 4
• 102000014777 Adipokines Human genes 0.000 description 3
• 108010078606 Adipokines Proteins 0.000 description 3
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 3
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 3
• 108091005471 CRHR1 Proteins 0.000 description 3
• 108091005470 CRHR2 Proteins 0.000 description 3
• 108010078791 Carrier Proteins Proteins 0.000 description 3
• 102000019034 Chemokines Human genes 0.000 description 3
• 108010012236 Chemokines Proteins 0.000 description 3
• 206010009944 Colon cancer Diseases 0.000 description 3
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
• 102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 description 3
• 102100038019 Corticotropin-releasing factor receptor 2 Human genes 0.000 description 3
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 3
• 108010078321 Guanylate Cyclase Proteins 0.000 description 3
• 102000014469 Guanylate cyclase Human genes 0.000 description 3
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 3
• 101000830742 Homo sapiens Tryptophan 5-hydroxylase 1 Proteins 0.000 description 3
• 102100031775 Leptin receptor Human genes 0.000 description 3
• 102100026799 Matrix metalloproteinase-28 Human genes 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 108010025020 Nerve Growth Factor Proteins 0.000 description 3
• 238000000636 Northern blotting Methods 0.000 description 3
• 108010013381 Porins Proteins 0.000 description 3
• 102000017033 Porins Human genes 0.000 description 3
• 102000006382 Ribonucleases Human genes 0.000 description 3
• 108010083644 Ribonucleases Proteins 0.000 description 3
• 108060008539 Transglutaminase Proteins 0.000 description 3
• 102100024971 Tryptophan 5-hydroxylase 1 Human genes 0.000 description 3
• 102100028786 Tumor necrosis factor receptor superfamily member 12A Human genes 0.000 description 3
• 208000019790 abdominal distention Diseases 0.000 description 3
• 210000001789 adipocyte Anatomy 0.000 description 3
• 239000000556 agonist Substances 0.000 description 3
• JSWZEAMFRNKZNL-UHFFFAOYSA-N alosetron Chemical compound N1C=NC(CN2C(C3=C(N(C4=CC=CC=C43)C)CC2)=O)=C1C JSWZEAMFRNKZNL-UHFFFAOYSA-N 0.000 description 3
• 230000002391 anti-complement effect Effects 0.000 description 3
• 108010008730 anticomplement Proteins 0.000 description 3
• 239000000935 antidepressant agent Substances 0.000 description 3
• 229940005513 antidepressants Drugs 0.000 description 3
• 230000015572 biosynthetic process Effects 0.000 description 3
• 229960002685 biotin Drugs 0.000 description 3
• 239000011616 biotin Substances 0.000 description 3
• 239000003467 chloride channel stimulating agent Substances 0.000 description 3
• 208000019902 chronic diarrheal disease Diseases 0.000 description 3
• 230000000112 colonic effect Effects 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 231100000673 dose–response relationship Toxicity 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 238000000605 extraction Methods 0.000 description 3
• 210000003495 flagella Anatomy 0.000 description 3
• 235000013305 food Nutrition 0.000 description 3
• 239000007789 gas Substances 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 210000003714 granulocyte Anatomy 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 229940099472 immunoglobulin a Drugs 0.000 description 3
• 229940027941 immunoglobulin g Drugs 0.000 description 3
• 230000002757 inflammatory effect Effects 0.000 description 3
• 230000028709 inflammatory response Effects 0.000 description 3
• 208000028774 intestinal disease Diseases 0.000 description 3
• 210000004347 intestinal mucosa Anatomy 0.000 description 3
• 210000000936 intestine Anatomy 0.000 description 3
• 108010019813 leptin receptors Proteins 0.000 description 3
• 210000002540 macrophage Anatomy 0.000 description 3
• CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 3
• 210000001616 monocyte Anatomy 0.000 description 3
• 210000003097 mucus Anatomy 0.000 description 3
• 229940053128 nerve growth factor Drugs 0.000 description 3
• 102000039446 nucleic acids Human genes 0.000 description 3
• 108020004707 nucleic acids Proteins 0.000 description 3
• 150000007523 nucleic acids Chemical class 0.000 description 3
• 210000002997 osteoclast Anatomy 0.000 description 3
• 230000007310 pathophysiology Effects 0.000 description 3
• 229940127293 prostanoid Drugs 0.000 description 3
• 150000003814 prostanoids Chemical class 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 108091000053 retinol binding Proteins 0.000 description 3
• 102000029752 retinol binding Human genes 0.000 description 3
• 239000000243 solution Substances 0.000 description 3
• 201000000498 stomach carcinoma Diseases 0.000 description 3
• 238000012706 support-vector machine Methods 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• 102000003601 transglutaminase Human genes 0.000 description 3
• 208000016261 weight loss Diseases 0.000 description 3
• 210000005253 yeast cell Anatomy 0.000 description 3
• BIAVGWDGIJKWRM-FQEVSTJZSA-N 3-hydroxy-2-phenyl-n-[(1s)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(O)C=1C1=CC=CC=C1 BIAVGWDGIJKWRM-FQEVSTJZSA-N 0.000 description 2
• 102100026802 72 kDa type IV collagenase Human genes 0.000 description 2
• 108010085238 Actins Proteins 0.000 description 2
• 102000007469 Actins Human genes 0.000 description 2
• 102100022954 Apolipoprotein D Human genes 0.000 description 2
• 108010025614 Apolipoproteins D Proteins 0.000 description 2
• 101710189812 Bilin-binding protein Proteins 0.000 description 2
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 2
• 102100023705 C-C motif chemokine 14 Human genes 0.000 description 2
• 102100023703 C-C motif chemokine 15 Human genes 0.000 description 2
• 102100023700 C-C motif chemokine 16 Human genes 0.000 description 2
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 2
• 102100036842 C-C motif chemokine 19 Human genes 0.000 description 2
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 2
• 102100036846 C-C motif chemokine 21 Human genes 0.000 description 2
• 102100036849 C-C motif chemokine 24 Human genes 0.000 description 2
• 102100021933 C-C motif chemokine 25 Human genes 0.000 description 2
• 102100021935 C-C motif chemokine 26 Human genes 0.000 description 2
• 102100021936 C-C motif chemokine 27 Human genes 0.000 description 2
• 102100021942 C-C motif chemokine 28 Human genes 0.000 description 2
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 2
• 102100034871 C-C motif chemokine 8 Human genes 0.000 description 2
• 101710098275 C-X-C motif chemokine 10 Proteins 0.000 description 2
• 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 2
• 102100025250 C-X-C motif chemokine 14 Human genes 0.000 description 2
• 102100039435 C-X-C motif chemokine 17 Human genes 0.000 description 2
• 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 2
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 2
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 2
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 2
• 102000005701 Calcium-Binding Proteins Human genes 0.000 description 2
• 108010045403 Calcium-Binding Proteins Proteins 0.000 description 2
• 208000005623 Carcinogenesis Diseases 0.000 description 2
• 102000000844 Cell Surface Receptors Human genes 0.000 description 2
• 108010001857 Cell Surface Receptors Proteins 0.000 description 2
• 108010055166 Chemokine CCL5 Proteins 0.000 description 2
• 108010062745 Chloride Channels Proteins 0.000 description 2
• 102000011045 Chloride Channels Human genes 0.000 description 2
• 241000193469 Clostridium pasteurianum Species 0.000 description 2
• 206010056979 Colitis microscopic Diseases 0.000 description 2
• 102100027995 Collagenase 3 Human genes 0.000 description 2
• 102000016911 Deoxyribonucleases Human genes 0.000 description 2
• 108010053770 Deoxyribonucleases Proteins 0.000 description 2
• 102100023688 Eotaxin Human genes 0.000 description 2
• 102000003951 Erythropoietin Human genes 0.000 description 2
• 108090000394 Erythropoietin Proteins 0.000 description 2
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
• 101001063955 Gallus gallus Extracellular fatty acid-binding protein Proteins 0.000 description 2
• 102100028953 Gelsolin Human genes 0.000 description 2
• 102000000393 Ghrelin Receptors Human genes 0.000 description 2
• 108010016122 Ghrelin Receptors Proteins 0.000 description 2
• 102000004240 Glycodelin Human genes 0.000 description 2
• 108010081520 Glycodelin Proteins 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 102000004858 Growth differentiation factor-9 Human genes 0.000 description 2
• 108090001086 Growth differentiation factor-9 Proteins 0.000 description 2
• 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
• 208000032843 Hemorrhage Diseases 0.000 description 2
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
• 102100021866 Hepatocyte growth factor Human genes 0.000 description 2
• 108010033040 Histones Proteins 0.000 description 2
• 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 2
• 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 2
• 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 description 2
• 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 description 2
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 2
• 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 description 2
• 101000897486 Homo sapiens C-C motif chemokine 25 Proteins 0.000 description 2
• 101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 description 2
• 101000858068 Homo sapiens C-X-C motif chemokine 14 Proteins 0.000 description 2
• 101000889048 Homo sapiens C-X-C motif chemokine 17 Proteins 0.000 description 2
• 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 2
• 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 2
• 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 2
• 101000627854 Homo sapiens Matrix metalloproteinase-26 Proteins 0.000 description 2
• 101000627861 Homo sapiens Matrix metalloproteinase-28 Proteins 0.000 description 2
• 101001125026 Homo sapiens Nucleotide-binding oligomerization domain-containing protein 2 Proteins 0.000 description 2
• 101000871708 Homo sapiens Proheparin-binding EGF-like growth factor Proteins 0.000 description 2
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 2
• 101000648505 Homo sapiens Tumor necrosis factor receptor superfamily member 12A Proteins 0.000 description 2
• 102100024022 Inactive heparanase-2 Human genes 0.000 description 2
• 101710133360 Inactive heparanase-2 Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• 206010022678 Intestinal infections Diseases 0.000 description 2
• 108010057281 Lipocalin 1 Proteins 0.000 description 2
• 102000003752 Lipocalin 1 Human genes 0.000 description 2
• 102100027998 Macrophage metalloelastase Human genes 0.000 description 2
• 206010025476 Malabsorption Diseases 0.000 description 2
• 208000004155 Malabsorption Syndromes Diseases 0.000 description 2
• 229920000057 Mannan Polymers 0.000 description 2
• 102100030417 Matrilysin Human genes 0.000 description 2
• 108090000855 Matrilysin Proteins 0.000 description 2
• 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
• 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
• 108090000609 Matrix metalloproteinase-20 Proteins 0.000 description 2
• 102100024130 Matrix metalloproteinase-23 Human genes 0.000 description 2
• 102100024128 Matrix metalloproteinase-26 Human genes 0.000 description 2
• 101100046559 Mus musculus Tnfrsf12a gene Proteins 0.000 description 2
• 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 2
• 108010056852 Myostatin Proteins 0.000 description 2
• 102000015336 Nerve Growth Factor Human genes 0.000 description 2
• 102400000097 Neurokinin A Human genes 0.000 description 2
• 101800000399 Neurokinin A Proteins 0.000 description 2
• HEAUFJZALFKPBA-YRVBCFNBSA-N Neurokinin A Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)O)C1=CC=CC=C1 HEAUFJZALFKPBA-YRVBCFNBSA-N 0.000 description 2
• 102000046798 Neurokinin B Human genes 0.000 description 2
• NHXYSAFTNPANFK-HDMCBQFHSA-N Neurokinin B Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(O)=O)C1=CC=CC=C1 NHXYSAFTNPANFK-HDMCBQFHSA-N 0.000 description 2
• 101800002813 Neurokinin-B Proteins 0.000 description 2
• 102000004230 Neurotrophin 3 Human genes 0.000 description 2
• 108090000742 Neurotrophin 3 Proteins 0.000 description 2
• 102000003683 Neurotrophin-4 Human genes 0.000 description 2
• 108090000099 Neurotrophin-4 Proteins 0.000 description 2
• 102100030411 Neutrophil collagenase Human genes 0.000 description 2
• 102100029441 Nucleotide-binding oligomerization domain-containing protein 2 Human genes 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 2
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
• 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 2
• 102000048176 Prostaglandin-D synthases Human genes 0.000 description 2
• 108030003866 Prostaglandin-D synthases Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 102100029812 Protein S100-A12 Human genes 0.000 description 2
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
• 102000014128 RANK Ligand Human genes 0.000 description 2
• 108010025832 RANK Ligand Proteins 0.000 description 2
• 101710137011 Retinol-binding protein 4 Proteins 0.000 description 2
• 102100038246 Retinol-binding protein 4 Human genes 0.000 description 2
• 206010070834 Sensitisation Diseases 0.000 description 2
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 2
• 102100028848 Stromelysin-2 Human genes 0.000 description 2
• 102100028847 Stromelysin-3 Human genes 0.000 description 2
• 108010008038 Synthetic Vaccines Proteins 0.000 description 2
• GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
• 102000036693 Thrombopoietin Human genes 0.000 description 2
• 108010041111 Thrombopoietin Proteins 0.000 description 2
• 101000638142 Treponema pallidum (strain Nichols) Membrane lipoprotein TmpC Proteins 0.000 description 2
• 102100040247 Tumor necrosis factor Human genes 0.000 description 2
• 101001011890 Xenopus laevis Matrix metalloproteinase-18 Proteins 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
• 229960003550 alosetron Drugs 0.000 description 2
• 230000033115 angiogenesis Effects 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 230000001387 anti-histamine Effects 0.000 description 2
• 230000003431 anti-prostaglandin Effects 0.000 description 2
• 230000002921 anti-spasmodic effect Effects 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 239000000739 antihistaminic agent Substances 0.000 description 2
• 229940124575 antispasmodic agent Drugs 0.000 description 2
• 239000012131 assay buffer Substances 0.000 description 2
• 229940125717 barbiturate Drugs 0.000 description 2
• 239000002585 base Substances 0.000 description 2
• 229940092732 belladonna alkaloid Drugs 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 239000003150 biochemical marker Substances 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• GERIGMSHTUAXSI-UHFFFAOYSA-N bis(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 4-phenyl-2,3-dihydro-1h-naphthalene-1,4-dicarboxylate Chemical compound CN1C(C2)CCC1CC2OC(=O)C(C1=CC=CC=C11)CCC1(C(=O)OC1CC2CCC(N2C)C1)C1=CC=CC=C1 GERIGMSHTUAXSI-UHFFFAOYSA-N 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 230000006583 body weight regulation Effects 0.000 description 2
• 230000036952 cancer formation Effects 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 231100000504 carcinogenesis Toxicity 0.000 description 2
• 230000020411 cell activation Effects 0.000 description 2
• 230000024245 cell differentiation Effects 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 208000037976 chronic inflammation Diseases 0.000 description 2
• 238000002052 colonoscopy Methods 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 210000000172 cytosol Anatomy 0.000 description 2
• 230000013872 defecation Effects 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 108010051768 des-n-octanoyl ghrelin Proteins 0.000 description 2
• 230000009266 disease activity Effects 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 210000002919 epithelial cell Anatomy 0.000 description 2
• 229960001123 epoprostenol Drugs 0.000 description 2
• 229940105423 erythropoietin Drugs 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 230000037406 food intake Effects 0.000 description 2
• 235000012631 food intake Nutrition 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 230000007149 gut brain axis pathway Effects 0.000 description 2
• 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 description 2
• 210000003016 hypothalamus Anatomy 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• 229960000511 lactulose Drugs 0.000 description 2
• JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 2
• PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 2
• 239000010410 layer Substances 0.000 description 2
• 108010024409 linaclotide Proteins 0.000 description 2
• WGFOBBZOWHGYQH-MXHNKVEKSA-N lubiprostone Chemical compound O1[C@](C(F)(F)CCCC)(O)CC[C@@H]2[C@@H](CCCCCCC(O)=O)C(=O)C[C@H]21 WGFOBBZOWHGYQH-MXHNKVEKSA-N 0.000 description 2
• 229960000345 lubiprostone Drugs 0.000 description 2
• 238000004020 luminiscence type Methods 0.000 description 2
• 208000004341 lymphocytic colitis Diseases 0.000 description 2
• 108090000280 major urinary proteins Proteins 0.000 description 2
• 102000003888 major urinary proteins Human genes 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 208000030159 metabolic disease Diseases 0.000 description 2
• 239000000203 mixture Substances 0.000 description 2
• 230000003990 molecular pathway Effects 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 210000004498 neuroglial cell Anatomy 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 229940032018 neurotrophin 3 Drugs 0.000 description 2
• 229940097998 neurotrophin 4 Drugs 0.000 description 2
• 230000003448 neutrophilic effect Effects 0.000 description 2
• 210000004940 nucleus Anatomy 0.000 description 2
• 102000052563 odorant-binding protein Human genes 0.000 description 2
• 108010000645 odorant-binding protein Proteins 0.000 description 2
• 229920001542 oligosaccharide Polymers 0.000 description 2
• 150000002482 oligosaccharides Chemical class 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• 238000012302 perinuclear staining Methods 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
• 108010042121 probasin Proteins 0.000 description 2
• KAQKFAOMNZTLHT-OZUDYXHBSA-M prostaglandin I2(1-) Chemical compound O1\C(=C/CCCC([O-])=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-M 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 238000003259 recombinant expression Methods 0.000 description 2
• 108091010987 retinoic acid binding proteins Proteins 0.000 description 2
• 108090000064 retinoic acid receptors Proteins 0.000 description 2
• 102000003702 retinoic acid receptors Human genes 0.000 description 2
• NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 230000008313 sensitization Effects 0.000 description 2
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
• 230000000405 serological effect Effects 0.000 description 2
• 239000003762 serotonin receptor affecting agent Substances 0.000 description 2
• 230000000697 serotonin reuptake Effects 0.000 description 2
• 230000001568 sexual effect Effects 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 239000002462 tachykinin receptor antagonist Substances 0.000 description 2
• 229950011332 talnetant Drugs 0.000 description 2
• 229960002876 tegaserod Drugs 0.000 description 2
• IKBKZGMPCYNSLU-RGVLZGJSSA-N tegaserod Chemical compound C1=C(OC)C=C2C(/C=N/NC(=N)NCCCCC)=CNC2=C1 IKBKZGMPCYNSLU-RGVLZGJSSA-N 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 238000012549 training Methods 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• RUJBDQSFYCKFAA-HNNXBMFYSA-N (5r)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine Chemical compound C1([C@H](C(=NN=2)C)CC)=CC(OC)=C(OC)C=C1C=2C1=CC=C(OC)C(OC)=C1 RUJBDQSFYCKFAA-HNNXBMFYSA-N 0.000 description 1
• TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
• IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical class C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 1
• SAURKKOJWIFYSR-UHFFFAOYSA-N 4-(2-fluorophenyl)-6-methyl-2-piperazin-1-ylthieno[2,3-d]pyrimidine;hydrate;hydrochloride Chemical compound O.Cl.N1=C2SC(C)=CC2=C(C=2C(=CC=CC=2)F)N=C1N1CCNCC1 SAURKKOJWIFYSR-UHFFFAOYSA-N 0.000 description 1
• YPELFRMCRYSPKZ-UHFFFAOYSA-N 4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide Chemical compound CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1OCCN(CC=2C=CC(F)=CC=2)C1 YPELFRMCRYSPKZ-UHFFFAOYSA-N 0.000 description 1
• RBCCQATUVPNPGQ-UHFFFAOYSA-N 4-hexadecylaniline Chemical compound CCCCCCCCCCCCCCCCC1=CC=C(N)C=C1 RBCCQATUVPNPGQ-UHFFFAOYSA-N 0.000 description 1
• 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
• 101800000263 Acidic protein Proteins 0.000 description 1
• 102400000069 Activation peptide Human genes 0.000 description 1
• 101800001401 Activation peptide Proteins 0.000 description 1
• 102000011690 Adiponectin Human genes 0.000 description 1
• 108010076365 Adiponectin Proteins 0.000 description 1
• 102000008704 Adseverin Human genes 0.000 description 1
• 102100027211 Albumin Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 208000019901 Anxiety disease Diseases 0.000 description 1
• 101710147666 Aphrodisin Proteins 0.000 description 1
• 241000893512 Aquifex aeolicus Species 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 235000007319 Avena orientalis Nutrition 0.000 description 1
• 244000075850 Avena orientalis Species 0.000 description 1
• 208000000412 Avitaminosis Diseases 0.000 description 1
• 108090000145 Bacillolysin Proteins 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 241000606125 Bacteroides Species 0.000 description 1
• 102000006734 Beta-Globulins Human genes 0.000 description 1
• 108010087504 Beta-Globulins Proteins 0.000 description 1
• 241000186000 Bifidobacterium Species 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
• 101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
• 102100023698 C-C motif chemokine 17 Human genes 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 101710112538 C-C motif chemokine 27 Proteins 0.000 description 1
• 101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
• 101710155833 C-C motif chemokine 8 Proteins 0.000 description 1
• 101710098272 C-X-C motif chemokine 11 Proteins 0.000 description 1
• 102100039396 C-X-C motif chemokine 16 Human genes 0.000 description 1
• 101710085504 C-X-C motif chemokine 6 Proteins 0.000 description 1
• 101710085500 C-X-C motif chemokine 9 Proteins 0.000 description 1
• 108010018054 CBir1 flagellin Proteins 0.000 description 1
• 101150049756 CCL6 gene Proteins 0.000 description 1
• 101150011672 CCL9 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102000000584 Calmodulin Human genes 0.000 description 1
• 108010041952 Calmodulin Proteins 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 101150075117 Ccl12 gene Proteins 0.000 description 1
• 108010075016 Ceruloplasmin Proteins 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 206010008399 Change of bowel habit Diseases 0.000 description 1
• 108010082155 Chemokine CCL18 Proteins 0.000 description 1
• 108010083647 Chemokine CCL24 Proteins 0.000 description 1
• 108010083698 Chemokine CCL26 Proteins 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 102100026096 Claudin-8 Human genes 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 108050005238 Collagenase 3 Proteins 0.000 description 1
• 108010056643 Corticotropin-Releasing Hormone Receptors Proteins 0.000 description 1
• 235000005956 Cosmos caudatus Nutrition 0.000 description 1
• 229920001393 Crofelemer Polymers 0.000 description 1
• 201000003883 Cystic fibrosis Diseases 0.000 description 1
• 150000008574 D-amino acids Chemical class 0.000 description 1
• 108090000082 Destrin Proteins 0.000 description 1
• 206010013530 Diverticula Diseases 0.000 description 1
• 206010013554 Diverticulum Diseases 0.000 description 1
• 108010024212 E-Selectin Proteins 0.000 description 1
• 102100023471 E-selectin Human genes 0.000 description 1
• 201000009273 Endometriosis Diseases 0.000 description 1
• 101710139422 Eotaxin Proteins 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 108050001049 Extracellular proteins Proteins 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 102000002090 Fibronectin type III Human genes 0.000 description 1
• 108050009401 Fibronectin type III Proteins 0.000 description 1
• 101710151190 Flagellin A Proteins 0.000 description 1
• 102100020997 Fractalkine Human genes 0.000 description 1
• 206010017367 Frequent bowel movements Diseases 0.000 description 1
• 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 description 1
• 208000005577 Gastroenteritis Diseases 0.000 description 1
• 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 108010068370 Glutens Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 108090000481 Heparin Cofactor II Proteins 0.000 description 1
• 102100030500 Heparin cofactor 2 Human genes 0.000 description 1
• 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 1
• 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 1
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
• 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 description 1
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
• 101000897494 Homo sapiens C-C motif chemokine 27 Proteins 0.000 description 1
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 description 1
• 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 1
• 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 description 1
• 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 1
• 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 1
• 101000889133 Homo sapiens C-X-C motif chemokine 16 Proteins 0.000 description 1
• 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 description 1
• 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
• 101100005560 Homo sapiens CCL23 gene Proteins 0.000 description 1
• 101000978392 Homo sapiens Eotaxin Proteins 0.000 description 1
• 101000854520 Homo sapiens Fractalkine Proteins 0.000 description 1
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
• 101000946124 Homo sapiens Lipocalin-1 Proteins 0.000 description 1
• 101001011896 Homo sapiens Matrix metalloproteinase-19 Proteins 0.000 description 1
• 101001125071 Homo sapiens Neuromedin-K receptor Proteins 0.000 description 1
• 101001073422 Homo sapiens Pigment epithelium-derived factor Proteins 0.000 description 1
• 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
• 101000600912 Homo sapiens Substance-K receptor Proteins 0.000 description 1
• 101000600903 Homo sapiens Substance-P receptor Proteins 0.000 description 1
• 240000005979 Hordeum vulgare Species 0.000 description 1
• 235000007340 Hordeum vulgare Nutrition 0.000 description 1
• 101100273566 Humulus lupulus CCL10 gene Proteins 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 206010021135 Hypovitaminosis Diseases 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 206010022489 Insulin Resistance Diseases 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 1
• 101710144554 Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 108010065637 Interleukin-23 Proteins 0.000 description 1
• 108010066979 Interleukin-27 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
• 108010038501 Interleukin-6 Receptors Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 102100026236 Interleukin-8 Human genes 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
• 108010070511 Keratin-8 Proteins 0.000 description 1
• 102000005712 Keratin-8 Human genes 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• 206010023648 Lactase deficiency Diseases 0.000 description 1
• 238000012897 Levenberg–Marquardt algorithm Methods 0.000 description 1
• 102100034724 Lipocalin-1 Human genes 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 101710187853 Macrophage metalloelastase Proteins 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 108010076497 Matrix Metalloproteinase 10 Proteins 0.000 description 1
• 108010076502 Matrix Metalloproteinase 11 Proteins 0.000 description 1
• 108010076501 Matrix Metalloproteinase 12 Proteins 0.000 description 1
• 108010076503 Matrix Metalloproteinase 13 Proteins 0.000 description 1
• 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 description 1
• 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 description 1
• 108010016160 Matrix Metalloproteinase 3 Proteins 0.000 description 1
• 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 1
• 108090000560 Matrix metalloproteinase-15 Proteins 0.000 description 1
• 102100030201 Matrix metalloproteinase-15 Human genes 0.000 description 1
• 108090000561 Matrix metalloproteinase-16 Proteins 0.000 description 1
• 102100030200 Matrix metalloproteinase-16 Human genes 0.000 description 1
• 108090000585 Matrix metalloproteinase-17 Proteins 0.000 description 1
• 102100030219 Matrix metalloproteinase-17 Human genes 0.000 description 1
• 108090000587 Matrix metalloproteinase-19 Proteins 0.000 description 1
• 102000004055 Matrix metalloproteinase-19 Human genes 0.000 description 1
• 102100030218 Matrix metalloproteinase-19 Human genes 0.000 description 1
• 102000004159 Matrix metalloproteinase-20 Human genes 0.000 description 1
• 102100029693 Matrix metalloproteinase-20 Human genes 0.000 description 1
• 101710082411 Matrix metalloproteinase-21 Proteins 0.000 description 1
• 108050006284 Matrix metalloproteinase-23 Proteins 0.000 description 1
• 102100024129 Matrix metalloproteinase-24 Human genes 0.000 description 1
• 108050005214 Matrix metalloproteinase-24 Proteins 0.000 description 1
• 102100024132 Matrix metalloproteinase-27 Human genes 0.000 description 1
• 108050005201 Matrix metalloproteinase-27 Proteins 0.000 description 1
• 102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 1
• 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 description 1
• 102100026261 Metalloproteinase inhibitor 3 Human genes 0.000 description 1
• 102100024289 Metalloproteinase inhibitor 4 Human genes 0.000 description 1
• 108050006579 Metalloproteinase inhibitor 4 Proteins 0.000 description 1
• 206010027452 Metastases to bone Diseases 0.000 description 1
• 206010061291 Mineral deficiency Diseases 0.000 description 1
• 206010061296 Motor dysfunction Diseases 0.000 description 1
• 206010028116 Mucosal inflammation Diseases 0.000 description 1
• 101000978374 Mus musculus C-C motif chemokine 12 Proteins 0.000 description 1
• 101100222387 Mus musculus Cxcl15 gene Proteins 0.000 description 1
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
• 101100454133 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) kstR2 gene Proteins 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 102000007072 Nerve Growth Factors Human genes 0.000 description 1
• 102100029409 Neuromedin-K receptor Human genes 0.000 description 1
• 108090000189 Neuropeptides Proteins 0.000 description 1
• 102000035092 Neutral proteases Human genes 0.000 description 1
• 108091005507 Neutral proteases Proteins 0.000 description 1
• 101710118230 Neutrophil collagenase Proteins 0.000 description 1
• 108030001564 Neutrophil collagenases Proteins 0.000 description 1
• 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 1
• 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 1
• 108091005461 Nucleic proteins Chemical group 0.000 description 1
• 229940127450 Opioid Agonists Drugs 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 101710203379 Outer membrane porin C Proteins 0.000 description 1
• 101710160101 Outer membrane protein C Proteins 0.000 description 1
• 208000012868 Overgrowth Diseases 0.000 description 1
• 108010070503 PAR-2 Receptor Proteins 0.000 description 1
• CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
• 108010035746 Pregnancy Proteins Proteins 0.000 description 1
• 102000008217 Pregnancy Proteins Human genes 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 102000018402 Protease-activated receptor 2 Human genes 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 101710110949 Protein S100-A12 Proteins 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 208000010362 Protozoan Infections Diseases 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 102000007156 Resistin Human genes 0.000 description 1
• 108010047909 Resistin Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 108700016890 S100A12 Proteins 0.000 description 1
• 241000235070 Saccharomyces Species 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 241000582914 Saccharomyces uvarum Species 0.000 description 1
• 241000209056 Secale Species 0.000 description 1
• 235000007238 Secale cereale Nutrition 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 244000062793 Sorghum vulgare Species 0.000 description 1
• 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
• 102100030416 Stromelysin-1 Human genes 0.000 description 1
• 101710108792 Stromelysin-2 Proteins 0.000 description 1
• 108050005271 Stromelysin-3 Proteins 0.000 description 1
• 102100037342 Substance-K receptor Human genes 0.000 description 1
• 102100037346 Substance-P receptor Human genes 0.000 description 1
• 108090000787 Subtilisin Proteins 0.000 description 1
• 108010014401 TWEAK Receptor Proteins 0.000 description 1
• 102000016946 TWEAK Receptor Human genes 0.000 description 1
• 108010072901 Tachykinin Receptors Proteins 0.000 description 1
• 102000007124 Tachykinin Receptors Human genes 0.000 description 1
• 108010031372 Tissue Inhibitor of Metalloproteinase-2 Proteins 0.000 description 1
• 108010031429 Tissue Inhibitor of Metalloproteinase-3 Proteins 0.000 description 1
• 102000014034 Transcortin Human genes 0.000 description 1
• 108010011095 Transcortin Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
• 235000019714 Triticale Nutrition 0.000 description 1
• 241000209140 Triticum Species 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 235000007264 Triticum durum Nutrition 0.000 description 1
• 235000004240 Triticum spelta Nutrition 0.000 description 1
• 240000003834 Triticum spelta Species 0.000 description 1
• 240000002805 Triticum turgidum Species 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 101710178416 Tumor necrosis factor receptor superfamily member 12A Proteins 0.000 description 1
• 102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 description 1
• LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
• 208000025865 Ulcer Diseases 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 102000036861 Zinc-dependent endopeptidases Human genes 0.000 description 1
• 108091006982 Zinc-dependent endopeptidases Proteins 0.000 description 1
• QWXOJIDBSHLIFI-UHFFFAOYSA-N [3-(1-chloro-3'-methoxyspiro[adamantane-4,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC2CC(Cl)(C4)C3)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 QWXOJIDBSHLIFI-UHFFFAOYSA-N 0.000 description 1
• IHBCFWWEZXPPLG-UHFFFAOYSA-N [Ca].[Zn] Chemical compound [Ca].[Zn] IHBCFWWEZXPPLG-UHFFFAOYSA-N 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 239000000478 adipokine Substances 0.000 description 1
• 210000000577 adipose tissue Anatomy 0.000 description 1
• 210000004100 adrenal gland Anatomy 0.000 description 1
• 210000003766 afferent neuron Anatomy 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
• 108090000183 alpha-2-Antiplasmin Proteins 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 230000006229 amino acid addition Effects 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 210000003484 anatomy Anatomy 0.000 description 1
• 230000001430 anti-depressive effect Effects 0.000 description 1
• 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000004019 antithrombin Substances 0.000 description 1
• 230000036506 anxiety Effects 0.000 description 1
• 230000001640 apoptogenic effect Effects 0.000 description 1
• JHLHNYVMZCADTC-LOSJGSFVSA-N asimadoline Chemical compound C([C@@H](N(C)C(=O)C(C=1C=CC=CC=1)C=1C=CC=CC=1)C=1C=CC=CC=1)N1CC[C@H](O)C1 JHLHNYVMZCADTC-LOSJGSFVSA-N 0.000 description 1
• 229950002202 asimadoline Drugs 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• LUEWUZLMQUOBSB-MHJOMNRISA-N beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-D-Manp Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H](OC(O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@@H](O)[C@H]1O LUEWUZLMQUOBSB-MHJOMNRISA-N 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 230000000035 biogenic effect Effects 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 229940112869 bone morphogenetic protein Drugs 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• JOCZJWVCEYOBNH-VPUKBDNTSA-N brevin Chemical compound O1C(C)C(O)C(OC)CC1OC1C(OC)CC(OC2C(CC(OC2C)OC2CC3=CCC4(O)C5(O)CCC(O)([C@@]5(C)C(O)C(OC(=O)C=5C=CC=CC=5)C4[C@@]3(C)CC2)C(C)=O)OC)OC1C JOCZJWVCEYOBNH-VPUKBDNTSA-N 0.000 description 1
• 239000004067 bulking agent Substances 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 230000004094 calcium homeostasis Effects 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 125000004432 carbon atom Chemical group C* 0.000 description 1
• 210000000748 cardiovascular system Anatomy 0.000 description 1
• 230000002026 carminative effect Effects 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 150000003943 catecholamines Chemical class 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000012292 cell migration Effects 0.000 description 1
• 230000009134 cell regulation Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 238000009388 chemical precipitation Methods 0.000 description 1
• 239000002727 chloride channel blocking agent Substances 0.000 description 1
• 210000001612 chondrocyte Anatomy 0.000 description 1
• 210000002987 choroid plexus Anatomy 0.000 description 1
• 230000006020 chronic inflammation Effects 0.000 description 1
• 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 239000003541 chymotrypsin inhibitor Substances 0.000 description 1
• 108090000239 claudin 8 Proteins 0.000 description 1
• 230000001149 cognitive effect Effects 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000010668 complexation reaction Methods 0.000 description 1
• 238000013329 compounding Methods 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 230000008602 contraction Effects 0.000 description 1
• 230000010485 coping Effects 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 229940047615 crofelemer Drugs 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 230000002354 daily effect Effects 0.000 description 1
• 230000007123 defense Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000000593 degrading effect Effects 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 229950009781 dextofisopam Drugs 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• 208000018554 digestive system carcinoma Diseases 0.000 description 1
• HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
• 229960004166 diltiazem Drugs 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 239000003210 dopamine receptor blocking agent Substances 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 230000002183 duodenal effect Effects 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 230000008482 dysregulation Effects 0.000 description 1
• 150000002066 eicosanoids Chemical class 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 239000006274 endogenous ligand Substances 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 210000002322 enterochromaffin cell Anatomy 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 108010003342 flaB flagellin Proteins 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 229940087051 fragmin Drugs 0.000 description 1
• 108010074605 gamma-Globulins Proteins 0.000 description 1
• 230000027119 gastric acid secretion Effects 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 230000030135 gastric motility Effects 0.000 description 1
• 230000007661 gastrointestinal function Effects 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 102000034238 globular proteins Human genes 0.000 description 1
• 108091005896 globular proteins Proteins 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 235000021312 gluten Nutrition 0.000 description 1
• 108010050792 glutenin Proteins 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 230000011132 hemopoiesis Effects 0.000 description 1
• 208000014617 hemorrhoid Diseases 0.000 description 1
• 239000000710 homodimer Substances 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 210000003405 ileum Anatomy 0.000 description 1
• 230000005934 immune activation Effects 0.000 description 1
• 230000005965 immune activity Effects 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 230000004968 inflammatory condition Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 230000003870 intestinal permeability Effects 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 210000001821 langerhans cell Anatomy 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 230000007108 local immune response Effects 0.000 description 1
• 230000006742 locomotor activity Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 229940060963 lotronex Drugs 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 238000010801 machine learning Methods 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
• 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
• 108090000440 matrix metalloproteinase 25 Proteins 0.000 description 1
• AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 description 1
• 210000002752 melanocyte Anatomy 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 210000003632 microfilament Anatomy 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 235000019713 millet Nutrition 0.000 description 1
• 229960004085 mosapride Drugs 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 210000001640 nerve ending Anatomy 0.000 description 1
• 210000000933 neural crest Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 239000003900 neurotrophic factor Substances 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 239000003402 opiate agonist Substances 0.000 description 1
• 229940005483 opioid analgesics Drugs 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 230000037324 pain perception Effects 0.000 description 1
• 210000002963 paraventricular hypothalamic nucleus Anatomy 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 239000000813 peptide hormone Substances 0.000 description 1
• 230000008447 perception Effects 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 210000001428 peripheral nervous system Anatomy 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 229960002036 phenytoin Drugs 0.000 description 1
• 239000003016 pheromone Substances 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 230000026341 positive regulation of angiogenesis Effects 0.000 description 1
• 230000006659 positive regulation of apoptotic process Effects 0.000 description 1
• 230000034918 positive regulation of cell growth Effects 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 description 1
• 230000002807 pro-secretory effect Effects 0.000 description 1
• 230000000529 probiotic effect Effects 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 150000003815 prostacyclins Chemical class 0.000 description 1
• 235000004252 protein component Nutrition 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• NTHPAPBPFQJABD-LLVKDONJSA-N ramosetron Chemical compound C12=CC=CC=C2N(C)C=C1C(=O)[C@H]1CC(NC=N2)=C2CC1 NTHPAPBPFQJABD-LLVKDONJSA-N 0.000 description 1
• 229950001588 ramosetron Drugs 0.000 description 1
• 108091006084 receptor activators Proteins 0.000 description 1
• 108700015048 receptor decoy activity proteins Proteins 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000024122 regulation of cell motility Effects 0.000 description 1
• 230000029892 regulation of protein phosphorylation Effects 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• GZSKEXSLDPEFPT-IINYFYTJSA-N renzapride Chemical compound COC1=CC(N)=C(Cl)C=C1C(=O)N[C@H]1[C@H](C2)CCC[N@]2CC1 GZSKEXSLDPEFPT-IINYFYTJSA-N 0.000 description 1
• 229950003039 renzapride Drugs 0.000 description 1
• 238000002271 resection Methods 0.000 description 1
• 230000003938 response to stress Effects 0.000 description 1
• 229960003471 retinol Drugs 0.000 description 1
• 235000020944 retinol Nutrition 0.000 description 1
• 239000011607 retinol Substances 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 230000033764 rhythmic process Effects 0.000 description 1
• PGKXDIMONUAMFR-AREMUKBSSA-N saredutant Chemical compound C([C@H](CN(C)C(=O)C=1C=CC=CC=1)C=1C=C(Cl)C(Cl)=CC=1)CN(CC1)CCC1(NC(C)=O)C1=CC=CC=C1 PGKXDIMONUAMFR-AREMUKBSSA-N 0.000 description 1
• 229950004387 saredutant Drugs 0.000 description 1
• 210000004116 schwann cell Anatomy 0.000 description 1
• 108010073419 scinderin Proteins 0.000 description 1
• 210000004739 secretory vesicle Anatomy 0.000 description 1
• 230000008786 sensory perception of smell Effects 0.000 description 1
• 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 description 1
• 239000000387 serotonin 5-HT4 receptor agonist Substances 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 description 1
• 201000009032 substance abuse Diseases 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 210000002437 synoviocyte Anatomy 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 210000004876 tela submucosa Anatomy 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 230000008719 thickening Effects 0.000 description 1
• 150000003595 thromboxanes Chemical class 0.000 description 1
• 229960004605 timolol Drugs 0.000 description 1
• 239000003204 tranquilizing agent Substances 0.000 description 1
• 230000002936 tranquilizing effect Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 108091008023 transcriptional regulators Proteins 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 239000002753 trypsin inhibitor Substances 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 108090000195 villin Proteins 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 230000009278 visceral effect Effects 0.000 description 1
• 208000009935 visceral pain Diseases 0.000 description 1
• 208000030401 vitamin deficiency disease Diseases 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• 241000228158 x Triticosecale Species 0.000 description 1
• 108010088577 zinc-binding protein Proteins 0.000 description 1
• 108010027843 zonulin Proteins 0.000 description 1